CClinicalTrials.gg
CompletedNCT02011243GIRDHUpdated Mar 26, 2015

Internal Rotation Deficit of the Glenohumeral Joint in Advanced-level Handball Players

An observational study in Internal Rotation Contracture-shoulder, Articulation Disorders and Athletic Injuries, sponsored by Centre Hospitalier Universitaire de Nīmes. Completed at 1 site in France. Per ClinicalTrials.gov, last updated 2015-03-26.

Sponsored by Centre Hospitalier Universitaire de Nīmes · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
86
Sex
All
01

Study summary

The main objective of this study is to estimate the incidence and prevalence of Internal Rotation Deficit (IRD) defined by a measure of IRD 2 (Internal Rotation Deficit in position 2) strictly greater than 20 ° in a population of advanced-level handball players over a training season.

Read the detailed description

The secondary objectives of this study are :

A- To estimate and compare the prevalence of Internal Rotation Deficit within groups

B- To assess the association between the Internal Rotation Deficit and the appearance of a shoulder pain and/or discomfort when throwing

C- To assess the association between Internal Rotation Deficit and the appearance of a shoulder pathology demonstrated by clinical examination by at least one abnormality in one of the following three tests: the arming apprehension test, the relocation test or the O'Brien test

D- Assess changes in values of IRD 2, the ratio IRD 2/GRE 2, and the Total Range of Motion over the training season

E- Evaluate the association between the values of IRD 2 and the appearance of shoulder pain or discomfort when throwing

F- To evaluate the association between IRD 2 values and the appearance of a shoulder pathology (at least one anomaly in one of three tests: the arming apprehension test, the relocation test or the O'Brien test).

G- To assess the association between values of the IRD 2/GRE 2 ratio and the appearance of shoulder pain or discomfort when throwing

H- To assess the association between values of the IRD 2/GRE 2 ratio and the appearance of a shoulder pathology (at least one anomaly in one of three tests: the arming apprehension test, the relocation test or the O'Brien test).

I- To estimate the optimal threshold value of the IRD 2/GRE 2 ratio that would define an Internal Rotation Deficit in a more relevant fashion as compred to the IRD 2 alone

02

Conditions studied

  • Internal Rotation Contracture-shoulder
  • Articulation Disorders
  • Athletic Injuries

Keywords

  • deficit
  • internal rotation
  • gleno humeral articulation
  • hand ball
03

In context

Contracture

151 studies on the registry are indexed under Contracture; 21 are open to participants now.

This study's enrollment of 86 is below the median of 100 across 35 observational studies indexed under Contracture.

Browse Contracture studies →

Lead sponsor

Centre Hospitalier Universitaire de Nīmes is the lead sponsor of 587 studies on the registry; 96 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population is composed of all members of the professional and pre-professional handball clubs in the city of Nîmes, France (the USAM and HBCN clubs). Younger players who are members of the training centers associated with these same clubs will also be included.

Inclusion criteria

  • The subject or his/her legal guardian must have given his/her informed and signed consent
  • The subject must be insured or beneficiary of a health insurance plan
  • The subject is a member of the professional and pre-professional handball clubs in Nîmes, France (the USAM or HBCN clubs) -- OR-- a member of the training centers associated with the same clubs whose parents or legal representatives have given informed consent

Exclusion criteria

Exclusion Criteria:

  • The subject is under judicial protection, under tutorship or curatorship
  • The subject or his/her legal respresentative refuses to sign the consent
  • It is impossible to correctly inform the subject
  • The subject is pregnant, parturient, or breastfeeding
  • The subject has been operated for shoulder instability, regardless of the surgical technique used
  • The subject has a history of fracture of the proximal end of the humerus and / or elbow
  • The subject has a history of rotator cuff surgery
  • The subject has neurological or spinal problems, or has received physiotherapy on the shoulder complex within 30 days prior to the study assessment
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
86 participants (actual)
Patient registry
No

Groups and cohorts

  • Professional players, men

    This group includes professional, male, handball players meeting study inclusion criteria.

  • Professional players, women

    This group includes professional, female, handball players meeting study inclusion criteria.

  • Junior players, men

    This group includes junior, male, handball players meeting study inclusion criteria.

  • Junior players, women

    This group includes junior, female, handball players meeting study inclusion criteria.

06

What researchers measure

Primary outcomes

  1. Presence/absence of an internal rotation deficit (IRD 2 > 20°)

    IRD 2 = internal rotation deficit in position 2 Position 2 = dominant arm in abduction at 90°

    Time frame: 6 months

Secondary outcomes

  1. Presence/absence of an internal rotation deficit (IRD 2 > 20°)

    Time frame: baseline (Day 0)

  2. Presence/absence of an internal rotation deficit (IRD 2 > 20°)

    Time frame: 3 months

  3. Measure of the internal rotation deficit

    Time frame: baseline (day 0)

  4. Measure of the internal rotation deficit

    Time frame: 3 months

  5. Measure of the internal rotation deficit

    Time frame: 6 months

  6. The ratio of DRI 2 / GRE 2

    GRE 2 = measure of the external gain in rotation in position 2 Position 2 = dominant arm in abduction at 90°

    Time frame: baseline (day 0)

  7. The ratio of DRI 2 / GRE 2

    Time frame: 3 months

  8. The ratio of DRI 2 / GRE 2

    Time frame: 6 months

  9. Measure of the total range of motion

    Time frame: baseline (day 0)

  10. Measure of the total range of motion

    Time frame: 3 months

  11. Measure of the total range of motion

    Time frame: 6 months

  12. Presence/absence of pain when throwing (yes/no)

    Time frame: baseline (day 0)

  13. Presence/absence of pain when throwing (yes/no)

    Time frame: 3 months

  14. Presence/absence of pain when throwing (yes/no)

    Time frame: 6 months

  15. Presence of discomfort when throwing (visual analog scale from 0 to 100)

    Time frame: baseline (day 0)

  16. Presence of discomfort when throwing (visual analog scale from 0 to 100)

    Time frame: 3 months

  17. Presence of discomfort when throwing (visual analog scale from 0 to 100)

    Time frame: 6 months

  18. Presence/absence of shoulder pathology

    Time frame: baseline (day 0)

  19. Presence/absence of shoulder pathology

    Time frame: 3 months

  20. Presence/absence of shoulder pathology

    Time frame: 6 months

  21. Shoulder clinical exam: the arming apprehension test

    Time frame: baseline (day 0)

  22. Shoulder clinical exam: the arming apprehension test

    Time frame: 3 months

  23. Shoulder clinical exam: the arming apprehension test

    Time frame: 6 months

  24. Shoulder clinical exam: relocation test

    Time frame: baseline (day 0)

  25. Shoulder clinical exam: relocation test

    Time frame: 3 months

  26. Shoulder clinical exam: relocation test

    Time frame: 6 months

  27. Shoulder clinical exam: the O'Brien test

    Time frame: baseline (day 0)

  28. Shoulder clinical exam: the O'Brien test

    Time frame: 3 months

  29. Shoulder clinical exam: the O'Brien test

    Time frame: 6 months

07

Study locations

1 site
  • CHRU de Nîmes - Hôpital Universitaire Carémeau
    Nîmes Cedex 9, 30029, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 26, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02011243
Lead sponsor
Centre Hospitalier Universitaire de Nīmes
Responsible party
Sponsor
First posted
Dec 13, 2013
Start date
Jan 2014
Primary completion
Aug 2014
Completion
Aug 2014
Last update
Mar 26, 2015

Study contacts

Olivier Marès, MD
principal investigator · Centre Hospitalier Universitaire de Nîmes

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion